Major cancer trial pits new drug against established treatment
NCT ID NCT07518186
Summary
This study will compare a new investigational drug called JNJ-79635322 against an existing treatment called teclistamab for people with multiple myeloma that has returned or stopped responding to previous therapies. The trial will involve about 700 participants whose cancer has progressed after 1-3 prior treatments. Researchers will measure which treatment works better at controlling the cancer and keeping it from progressing.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.